Effectiveness of Corticosteroid vs. Ketorolac Shoulder Injections: A Prospective Double-Blinded Randomized Trial

• Status: Suspended
• Trial end date: 2023-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the functional outcomes of patients with shoulder pathology treated with either ketorolac or corticosteroid injections, in a randomized double-blinded study. Investigators will compare the effectiveness of ketorolac compared to corticosteroid.

Specific Aim 1:

Hypothesis 1: Injection of the shoulder (in the subacromial space) with Ketorolac will be more effective than corticosteroid injection for the treatment of a variety of shoulder pathologies.

The risks associated with this study primarily concern adverse reactions to the study drugs. The drugs used in this study are not narcotics or habit-forming but can have side effects. The patient's physician will screen for any heart, intestinal, or kidney disease or condition that would increase the chance for the patient to have an unwanted side effect.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Michael Khazzam; University of Texas Southwestern Medical Center
• Treatments: Bupivacaine; Epinephrine; Epinephryl borate; Ketorolac; Ketorolac Tromethamine; Racepinephrine; Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• Rotator Cuff Tendinitis

• Atraumatic Rotator Cuff Tear

• Rotator Cuff Tear Arthropathy

• Subjects who speak English

Exclusion Criteria:

• Age: < 18 years old

• Prior Shoulder Surgery

• Fracture

• Acute Traumatic Rotator Cuff Tear

• Infection

• Uncontrolled Diabetes Mellitus (HbA1c >8)

• Recent Prior Shoulder Injection in either the Subacromial space

• Workers Compensation

• History of Gastric Ulcers

• Tumor Involving the Shoulder Region

• Prior history of gastrointestinal bleeding, allergic reactions, impaired renal function, seizures or cardiac arrhythmias

• Subject unable to provide informed consent

• Subjects who don't speak English

• Patients who are pregnant or lactating at time of screening or are of child bearing age

• Patients currently receiving an aspirin, NSAID regimen or any other anti-inflammatory agents that could affect inflammation response.

• Patients with any bleeding disorders.

• Patients with severe renal failure.

• Patients likely to have severe problems maintaining follow-up, including patients diagnosed with severe psychiatric conditions, patients who live too far outside the hospital's catchment area, patients who are incarcerated and patients who have unstable housing situations.

• Patients who are allergic to aspirin, ketorolac tromethamine and other NSAIDs